Flexibilities in controlled substances prescribing and dispensing during the COVID-19 pandemic
- Collection:
- Health Policy and Services Research
- Series Title(s):
- ASPE issue brief
- Contributor(s):
- United States. Department of Health and Human Services. Office of Science and Data Policy, issuing body.
- Publication:
- Washington, D.C. : Assistant Secretary for Planning and Evaluation, Office of Science & Data Policy, August 2022
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Controlled Substances -- supply & distribution COVID-19 Electronic Prescribing Federal Government Health Services Accessibility Opiate Substitution Treatment State Government United States
- Genre(s):
- Technical Report
- Abstract:
- The federal government issued a range of flexibilities around telehealth, medications for opioid use disorder, licensing, and emergency prescribing to improve access to controlled substances and medications for opioid use disorder during the COVID-19 pandemic. States relaxed or suspended regulations to allow for the implementation of federally-issued flexibilities, and also issued unique flexibilities related to controlled substance prescribing. Flexibilities allowing for the use of telehealth for controlled substance prescribing and medications for opioid use disorder were the most common flexibilities implemented by states. This brief summarizes federal and state flexibilities around controlled substance prescribing in response to the COVID-19 pandemic, enabling analysis of the impacts on prescribing and patient access.
- Copyright:
- The National Library of Medicine believes this item to be in the public domain. (More information)
- Extent:
- 1 online resource (1 PDF file (9 pages))
- Illustrations:
- Illustrations
- NLM Unique ID:
- 9918539488306676 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/9918539488306676